Progress in precision treatment of type 1 diabetes: 3 injections of vaccine have a substantial increase in insulin secretion
Express has shown efficacy for SMA patients aged 1-60 years, and the latest clinical results of Roche's innovative oral therapy are positive
Ruike Biotechnology completes nearly RMB 1 billion in Series C financing
Type 1 and 2 diabetes have ushered in new progress: support for approval, introduction of authorization...
1. Type 2 diabetes has ushered in new progress: support for approval, guideline recommendation, introduction authorization...
Sansheng Guojian HER2/PD-1 bispecific antibody was approved by the U.S. FDA...
Pharmaceutical financing ViaCyte raised US$45 million to promote stem cell-derived therapies for type 1 diabetes
[Nature Sub-Journal] A new breakthrough in type 1 diabetes: The new method actually makes the differentiation rate of pancreatic islet β cells as high as 80%?
Cell's important finding: The presence of type I natural antibodies similar to 2G12 antibodies in the human body may become a new target for HIV-1 vaccines
Hans Biotech initiates Phase 2 clinical trial of CD47/PD-1 bispecific antibody
Sell 1 catty and lose 1 yuan!
Betta Pharmaceuticals PD-1 batilimumab was approved for clinical use
Hengrui PD-1 new indication approved: first-line treatment of nasopharyngeal carcinoma
Initiation of triple immunization program clinical trial for PD-1/L1 monoclonal antibody treatment of drug-resistant prenabulin
The clinical advantage of Lepu Bio's differential PD-1 monoclonal antibody is beginning to show
for immunotherapy of solid tumors with PD-1 antibody empowered by hyperbaric oxygen
The third indication of Cinda PD-1 was approved as the first-line treatment for squamous NSCLC
Latest research: Immunity can be maintained for at least 1 year after being infected with the new crown
Cancers: Efficacy and safety of radiotherapy combined with S-1 in the treatment of head and neck tumors: from a Meta analysis
Diabetes Care: The prevalence of ketoacidosis in adolescents with type 1 diabetes has increased at the time of diagnosis